Cost-effectiveness of self-expandable transcatheter aortic valves in intermediate-risk patients

DY Tam, A Hughes, HC Wijeysundera… - The Annals of thoracic …, 2018 - Elsevier
Background A recent clinical trial showed that self-expandable transcatheter aortic valve
replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However …

Cost-effectiveness and projected survival of self-expanding transcatheter versus surgical aortic valve replacement for high risk patients in a European setting: a Dutch …

BP Geisler, SA Huygens, MJ Reardon… - Structural …, 2017 - Taylor & Francis
Background: Clinical and economic outcomes of self-expanding bioprosthetic transcatheter
aortic valve implantation (TAVI) in high-risk surgical candidates are unknown in the …

The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis

DY Tam, PM Azizi, SE Fremes, J Chikwe… - … Journal-Quality of …, 2021 - academic.oup.com
Aims The economic value of transcatheter aortic valve replacement (TAVR) in low surgical
risk patients with severe, symptomatic aortic stenosis is not known. Our objective was to …

Cost-effectiveness of transcatheter versus surgical aortic valve replacement in low-risk patients with severe aortic stenosis

JY Zhou, D Liew, SJ Duffy, A Walton, N Htun… - Heart, Lung and …, 2021 - Elsevier
Background Recent studies have shown that transcatheter aortic valve implantation (TAVI) is
non-inferior to surgical aortic valve replacement (SAVR) for treatment of low-risk patients …

Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of …

MR Reynolds, EA Magnuson, Y Lei, K Wang… - Journal of the American …, 2012 - jacc.org
Objectives: The aim of this study was to evaluate the cost-effectiveness of transcatheter
aortic valve replacement (TAVR) compared with surgical aortic valve replacement (AVR) for …

Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement

MR Reynolds, Y Lei, K Wang… - Journal of the American …, 2016 - jacc.org
Background: Previous studies of the cost-effectiveness of transcatheter aortic valve
replacement (TAVR) have been based primarily on a single balloon-expandable system …

Cost-effectiveness of transcatheter aortic valve intervention (TAVI) compared to surgical aortic valve replacement (SAVR) in low-to intermediate-surgical-risk patients

M Azraai, L Gao, AE Ajani - Cardiovascular Revascularization Medicine, 2020 - Elsevier
Introduction Transcatheter aortic valve intervention (TAVI) is known to be non-inferior to
surgical aortic valve replacement (SAVR) in low-intermediate surgical risk patients. This …

Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the …

MR Reynolds, EA Magnuson, K Wang, Y Lei, K Vilain… - Circulation, 2012 - Am Heart Assoc
Background—In patients with severe aortic stenosis who cannot have surgery, transcatheter
aortic valve replacement (TAVR) has been shown to improve survival and quality of life …

[HTML][HTML] Systematic review of the cost-effectiveness of transcatheter aortic valve implantation

P Indraratna, SC Ang, H Gada, TD Yan… - The Journal of thoracic …, 2014 - Elsevier
Objective Transcatheter aortic valve implantation (TAVI) has emerged as an alternative
treatment to aortic valve replacement (AVR) for selected patients with severe aortic stenosis …

Contemporary costs associated with transcatheter versus surgical aortic valve replacement in medicare beneficiaries

SJ Baron, MP Ryan, KA Moore, SJ Clancy… - Circulation …, 2022 - Am Heart Assoc
Background: In patients with severe aortic stenosis, treatment with transcatheter aortic valve
replacement (TAVR) has been shown to be cost-effective in the high-risk surgical population …